MarketBeat Instant News Alerts 2 hours agoExlService (NASDAQ:EXLS) Given "Buy (B-)" Rating at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "buy (b-)" rating on shares of ExlService in a research note on Wednesday.NASDAQ:EXLSRead ExlService (NASDAQ:EXLS) Given "Buy (B-)" Rating at Weiss Ratings2 hours agoExpensify's (EXFY) Sell (E+) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (e+)" rating on shares of Expensify in a research note on Wednesday.NASDAQ:EXFYRead Expensify's (EXFY) Sell (E+) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Buy (B) Rating for Exelixis (NASDAQ:EXEL)MarketBeatWeiss Ratings reiterated a "buy (b)" rating on shares of Exelixis in a research report on Wednesday.NASDAQ:EXELRead Weiss Ratings Reiterates Buy (B) Rating for Exelixis (NASDAQ:EXEL)2 hours agoExpand Energy (NASDAQ:EXE) Given Hold (C-) Rating at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "hold (c-)" rating on shares of Expand Energy in a report on Wednesday.NASDAQ:EXERead Expand Energy (NASDAQ:EXE) Given Hold (C-) Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B-) Rating for Exelon (NASDAQ:EXC)MarketBeatWeiss Ratings restated a "buy (b-)" rating on shares of Exelon in a research report on Wednesday.NASDAQ:EXCRead Weiss Ratings Reaffirms Buy (B-) Rating for Exelon (NASDAQ:EXC)2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Exact Sciences (NASDAQ:EXAS)MarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Exact Sciences in a research report on Wednesday.NASDAQ:EXASRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Exact Sciences (NASDAQ:EXAS) Trending News1Quantum Computing Stocks To Keep An Eye On - October 7th2Zacks Research Issues Pessimistic Outlook for NIO Earnings3AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital4Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?5MBL Wealth LLC Makes New $591,000 Investment in Solid Power, Inc. $SLDP6Penny Stocks To Watch Now - October 4th7IonQ (NYSE:IONQ) Shares Down 4.3% - Here's What Happened8DraftKings (NASDAQ:DKNG) Shares Down 4.7% Following Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoEvergy's (EVRG) "Buy (B-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:EVRGRead Evergy's (EVRG) "Buy (B-)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (E+)" Rating for Evotec (NASDAQ:EVO)MarketBeatNASDAQ:EVORead Weiss Ratings Reiterates "Sell (E+)" Rating for Evotec (NASDAQ:EVO)2 hours agoEvolv Technologies (NASDAQ:EVLV) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:EVLVRead Evolv Technologies (NASDAQ:EVLV) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoEVgo's (EVGO) Sell (D-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:EVGORead EVgo's (EVGO) Sell (D-) Rating Reiterated at Weiss Ratings2 hours agoEverQuote (NASDAQ:EVER) Receives "Hold (C)" Rating from Weiss RatingsMarketBeatNASDAQ:EVERRead EverQuote (NASDAQ:EVER) Receives "Hold (C)" Rating from Weiss Ratings2 hours agoEverCommerce's (EVCM) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:EVCMRead EverCommerce's (EVCM) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoEtsy (NASDAQ:ETSY) Upgraded by Weiss Ratings to Hold (C-) RatingMarketBeatNASDAQ:ETSYRead Etsy (NASDAQ:ETSY) Upgraded by Weiss Ratings to Hold (C-) Rating2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Eton Pharmaceuticals (NASDAQ:ETON)MarketBeatNASDAQ:ETONRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Eton Pharmaceuticals (NASDAQ:ETON)2 hours agoFlag Ship Acquisition (NASDAQ:ETHZ) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:ETHZRead Flag Ship Acquisition (NASDAQ:ETHZ) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoEstablishment Labs' (ESTA) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ESTARead Establishment Labs' (ESTA) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoEsquire Financial's (ESQ) "Buy (B)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ESQRead Esquire Financial's (ESQ) "Buy (B)" Rating Reaffirmed at Weiss Ratings2 hours agoEsperion Therapeutics (NASDAQ:ESPR) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:ESPRRead Esperion Therapeutics (NASDAQ:ESPR) Earns Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Buy (B-) Rating for Euroseas (NASDAQ:ESEA)MarketBeatNASDAQ:ESEARead Weiss Ratings Reiterates Buy (B-) Rating for Euroseas (NASDAQ:ESEA)2 hours agoWeiss Ratings Reaffirms "Hold (C)" Rating for Escalade (NASDAQ:ESCA)MarketBeatNASDAQ:ESCARead Weiss Ratings Reaffirms "Hold (C)" Rating for Escalade (NASDAQ:ESCA)2 hours agoEricsson (NASDAQ:ERIC) Earns "Hold (C+)" Rating from Weiss RatingsMarketBeatNASDAQ:ERICRead Ericsson (NASDAQ:ERIC) Earns "Hold (C+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Eupraxia Pharmaceuticals (NASDAQ:EPRX)MarketBeatNASDAQ:EPRXRead Weiss Ratings Reaffirms Sell (D-) Rating for Eupraxia Pharmaceuticals (NASDAQ:EPRX)2 hours agoThe Ensign Group's (ENSG) Buy (B) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ENSGRead The Ensign Group's (ENSG) Buy (B) Rating Reiterated at Weiss Ratings2 hours agoEastern (NASDAQ:EML) Earns "Sell (D+)" Rating from Weiss RatingsMarketBeatNASDAQ:EMLRead Eastern (NASDAQ:EML) Earns "Sell (D+)" Rating from Weiss Ratings2 hours agoEuronet Worldwide's (EEFT) Hold (C) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:EEFTRead Euronet Worldwide's (EEFT) Hold (C) Rating Reiterated at Weiss Ratings2 hours agoPrecision BioSciences (NASDAQ:DTIL) Earns "Sell (E+)" Rating from Weiss RatingsMarketBeatNASDAQ:DTILRead Precision BioSciences (NASDAQ:DTIL) Earns "Sell (E+)" Rating from Weiss Ratings2 hours agoThe Descartes Systems Group (NASDAQ:DSGX) Receives Hold (C+) Rating from Weiss RatingsMarketBeatNASDAQ:DSGXRead The Descartes Systems Group (NASDAQ:DSGX) Receives Hold (C+) Rating from Weiss Ratings2 hours agoLeonardo DRS (NASDAQ:DRS) Given Buy (B) Rating at Weiss RatingsMarketBeatNASDAQ:DRSRead Leonardo DRS (NASDAQ:DRS) Given Buy (B) Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (E+) Rating for Krispy Kreme (NASDAQ:DNUT)MarketBeatNASDAQ:DNUTRead Weiss Ratings Reaffirms Sell (E+) Rating for Krispy Kreme (NASDAQ:DNUT)2 hours agoESAB (NYSE:ESAB) Given "Buy (B)" Rating at Weiss RatingsMarketBeatNYSE:ESABRead ESAB (NYSE:ESAB) Given "Buy (B)" Rating at Weiss Ratings Featured Articles and Offers3 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 2025Trump's Law S.1582: $21T Dollar Revolution ComingFrom Brownstone Research (Ad)General Dynamics Hits New Highs: Why It Might Keep ClimbingBy Jeffrey Neal Johnson | October 2, 2025Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025NVIDIA Breaks Out to New Highs: What Comes Next?By Thomas Hughes | October 2, 2025Capital Gains Tax Strategies for SeniorsFrom SmartAsset (Ad)Archer Aviation (NYSE:ACHR) Stock Price Up 13.2% - Here's WhyBy MarketBeat | October 3, 2025Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryBy Thomas Hughes | October 2, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
